HCV and diabetes: towards a 'sustained' glycaemic improvement after treatment with DAAs?

Clin Microbiol Infect. 2017 May;23(5):342-343. doi: 10.1016/j.cmi.2016.09.021. Epub 2016 Sep 29.

Authors

C Fabrizio¹, A Procopio¹, L Scudeller², R Dell'Acqua¹, G Bruno¹, E Milano¹, M Milella¹, A Saracino³, G Angarano¹

Affiliations

¹ Clinic of Infectious Diseases, University of Bari, Bari, Italy.
² Scientific Direction, Clinical Epidemiology Unit, IRCCS San Matteo Foundation, Pavia, Italy.
³ Clinic of Infectious Diseases, University of Bari, Bari, Italy. Electronic address: annalisa.saracino@uniba.it.

PMID: 27693659
DOI: 10.1016/j.cmi.2016.09.021

No abstract available

Publication types

Letter
Comment

MeSH terms

Antiviral Agents
Blood Glucose*
Diabetes Mellitus
Hepatitis C, Chronic*
Humans

Substances

Antiviral Agents
Blood Glucose